CClinicalTrials.gg
CompletedNCT01842100Updated Apr 29, 2013

To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy

An interventional study of Universal antibiotic prophylaxis and Screen-and-treat in Induced Abortion, Postaboral Pelvic Inflammatory Disease and Sexually Transmitted Infections, sponsored by The University of Hong Kong. Completed at 1 site in China. Open to female participants. Per ClinicalTrials.gov, last updated 2013-04-29.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
2,193
Allocation
Randomized
Sex
Female
01

Study summary

Screen-and-treat approach reduces postabortal pelvic inflammatory disease after induced abortion, and at the same time alters women's sexual behavior and prevents further re-infection by sexually transmitted infections when compared to the universal antibiotic prophylaxis strategy.

Read the detailed description

While universal antibiotic prophylaxis during induced abortion has been proven to reduce postabortal pelvic inflammatory diseases, screen-and-treat approach has the potential benefit of altering women's sexual behavior and preventing further re-infection by sexually transmitted infections. We conducted a randomized controlled trial to compare the effect of the two approaches in preventing postabortal pelvic inflammatory disease and the women's sexual behavior.

02

Conditions studied

  • Induced Abortion
  • Postaboral Pelvic Inflammatory Disease
  • Sexually Transmitted Infections

Keywords

  • Induced abortion
  • Postaboral pelvic inflammatory disease
  • Sexually transmitted infections
  • Universal antibiotic prophylaxis
  • Screen-and-treat approach
03

In context

Infections

6,687 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's enrollment of 2,193 is above the median of 120 across 4,200 interventional studies indexed under Infections.

Browse Infections studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • women requesting for induced abortion in the gynecology clinic

Exclusion criteria

Exclusion Criteria:

  • nil
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,193 participants (actual)

Study arms

  • Active comparator
    Universal antibiotic prophylaxis

    In the universal prophylaxis group, all women received doxycycline 100 mg twice daily for 7 days starting on the day of induced abortion. Screening for sexually transmitted diseases was done as baseline but the results were not revealed to the patients.

    Drug: Universal antibiotic prophylaxis

  • Active comparator
    Screen-and-treat

    In the screen-and-treat group, the results of screening for sexually transmitted infections (STI) were revealed to the patients. They would only receive appropriate specific antibiotics treatment only if they were screened positive for any of the STIs. If they were found to have STI, their sexual partners would also be referred to the local social hygiene clinics for contact tracing and treatment. Contraception by barrier methods would also be advised.

    Other: Screen-and-treat

Interventions

  • DrugUniversal antibiotic prophylaxis

    100 mg twice daily for 7 days starting on the day of induced abortion

  • OtherScreen-and-treat

    Specific antibiotic treatment was only given if the women was found to have sexually transmitted infection(s) on screening.

06

What researchers measure

Primary outcomes

  1. Rate of postabortal inflammatory disease 6 weeks after induced abortion.

    Time frame: 6 weeks after induced abortion.

Secondary outcomes

  1. Rate of re-infection by sexually transmitted infections 24 weeks after induced abortion.

    Time frame: 24 weeks after induced abortion.

  2. Proportion of women having abstinence from sexual intercourse or using condom at 6 weeks, 24 weeks and 1 year after induced abortion.

    Time frame: 6 weeks, 24 weeks and 1 year after induced abortion

07

Study locations

1 site
  • Queen Mary Hospital
    Hong Kong, Hong Kong, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01842100
Lead sponsor
The University of Hong Kong
Responsible party
Sponsor
First posted
Apr 29, 2013
Start date
Sep 1999
Primary completion
Feb 2006
Completion
Feb 2006
Last update
Apr 29, 2013

Study contacts

Sofie SF Yung, MBBS, MRCOG
principal investigator · The University of Hong Kong

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion